Rare diseases
Thought Leadership
The impact of real-world data in gaining access to the European orphan drugs market.
News
Sciensus partners with ITN and Genetic Alliance UK for Rare Disease Day
Thought Leadership
Navigating expanded access in Europe: a strategic blueprint for biotech leaders
Blog
Accessing and supporting EU rare disease patients: a quick guide
Blog
Early access programs – benefits, challenges and the Sciensus solution
Case Studies
Developing a comprehensive support program in Europe
Case Studies
How Sciensus supported the launch of a breakthrough therapy in Europe and beyond
Thought Leadership
Strategies for entering the European orphan drugs market
Thought Leadership
Realize your European orphan drug expansion